{"id":1424,"date":"2024-11-01T15:00:00","date_gmt":"2024-11-01T06:00:00","guid":{"rendered":"https:\/\/www.lifescience.shokubai.co.jp\/?post_type=news&#038;p=1424"},"modified":"2024-11-01T14:36:01","modified_gmt":"2024-11-01T05:36:01","slug":"nippon-shokubai-to-exhibit-at-tides-europe-2024","status":"publish","type":"news","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/","title":{"rendered":"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"743\" height=\"115\" src=\"https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2024\/10\/logo_TIDES-EUROPE-1.png\" alt=\"TIDES EUROPE \u30ed\u30b4\u753b\u50cf\" class=\"wp-image-1411\" srcset=\"https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2024\/10\/logo_TIDES-EUROPE-1.png 743w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2024\/10\/logo_TIDES-EUROPE-1-300x46.png 300w\" sizes=\"auto, (max-width: 743px) 100vw, 743px\" \/><\/figure>\n\n\n\n<div style=\"height:42px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Nippon Shokubai is going to exhibit at \u201c<a href=\"https:\/\/informaconnect.com\/tides-europe\/\">TIDES EUROPE 2024<\/a>\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.<br>We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory research to clinical trials, thereby contributing to the development of therapeutic technologies in disease areas with low treatment satisfaction. <br>We look forward to meeting you at the exhibition and having fruitful discussions.<\/p>\n\n\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"letter-spacing:1px\">\u3010Date\u301112th &#8211; 14th Nov. 2024<br>\u3010Place\u3011Hamburg Congress Center. Hamburg, Germany<br>\u3010Our booth\u3011412<br>\u3010Our title in the Exhibition\u3011Comprehensive oligonucleotide and peptide APIs solutions with Nippon Shokubai.\u3000<a href=\"https:\/\/informaconnect.com\/tides-europe\/sponsors\/nippon-shokubai-co-ltd\/\" target=\"_blank\" rel=\"noopener\" title=\"\">For more information:<\/a><br>\u3010How to attend\u3011TIDES EUROPE 2024 offers several passes. Please visit the <a href=\"https:\/\/informaconnect.com\/tides-europe\/\" target=\"_blank\" rel=\"noopener\" title=\"\">official website<\/a> and register.<br>\u3010Our contact info.\u3011\u3000NIPPON SHOKUBAI CO., LTD. Health &amp; Medical Business Division<br>E-mail\uff1a<a href=\"mailto:health_medical@shokubai.co.jp\" target=\"_blank\" rel=\"noopener\" title=\"\">health_medical@shokubai.co.jp<\/a><\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"featured_media":0,"template":"","news_category":[15],"class_list":["post-1424","news","type-news","status-publish","hentry","news_category-event-en"],"acf":{"blank_url":"","pdf_url":null,"select_link":"single_link"},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Nippon Shokubai is going to exhibit at \u201cTIDES EUROPE 2024\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"NIPPON SHOKUBAI | Nippon Shokubai\u2019s Health &amp; Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c | NIPPON SHOKUBAI\" \/>\n\t\t<meta property=\"og:description\" content=\"Nippon Shokubai is going to exhibit at \u201cTIDES EUROPE 2024\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-11-01T06:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-11-01T05:36:01+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c | NIPPON SHOKUBAI\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Nippon Shokubai is going to exhibit at \u201cTIDES EUROPE 2024\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1424\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#listItem\",\"position\":1,\"name\":\"\\u5bb6\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/event-en\\\/#listItem\",\"name\":\"Event\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#listItem\",\"name\":\"\\u5bb6\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/event-en\\\/#listItem\",\"position\":3,\"name\":\"Event\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/event-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1424\\\/#listItem\",\"name\":\"Nippon Shokubai to Exhibit at \\u201cTIDES EUROPE 2024\\u201c\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1424\\\/#listItem\",\"position\":4,\"name\":\"Nippon Shokubai to Exhibit at \\u201cTIDES EUROPE 2024\\u201c\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/event-en\\\/#listItem\",\"name\":\"Event\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#organization\",\"name\":\"\\u682a\\u5f0f\\u4f1a\\u793e\\u65e5\\u672c\\u89e6\\u5a92\",\"description\":\"Nippon Shokubai\\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1424\\\/#webpage\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1424\\\/\",\"name\":\"Nippon Shokubai to Exhibit at \\u201cTIDES EUROPE 2024\\u201c | NIPPON SHOKUBAI\",\"description\":\"Nippon Shokubai is going to exhibit at \\u201cTIDES EUROPE 2024\\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1424\\\/#breadcrumblist\"},\"datePublished\":\"2024-11-01T15:00:00+09:00\",\"dateModified\":\"2024-11-01T14:36:01+09:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\",\"name\":\"\\u682a\\u5f0f\\u4f1a\\u793e\\u65e5\\u672c\\u89e6\\u5a92\",\"description\":\"Nippon Shokubai\\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c | NIPPON SHOKUBAI","description":"Nippon Shokubai is going to exhibit at \u201cTIDES EUROPE 2024\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory","canonical_url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#listItem","position":1,"name":"\u5bb6","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","position":2,"name":"News","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/#listItem","name":"Event"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#listItem","name":"\u5bb6"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/#listItem","position":3,"name":"Event","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/#listItem","name":"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/#listItem","position":4,"name":"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c","previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/#listItem","name":"Event"}}]},{"@type":"Organization","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#organization","name":"\u682a\u5f0f\u4f1a\u793e\u65e5\u672c\u89e6\u5a92","description":"Nippon Shokubai\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/"},{"@type":"WebPage","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/#webpage","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/","name":"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c | NIPPON SHOKUBAI","description":"Nippon Shokubai is going to exhibit at \u201cTIDES EUROPE 2024\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/#breadcrumblist"},"datePublished":"2024-11-01T15:00:00+09:00","dateModified":"2024-11-01T14:36:01+09:00"},{"@type":"WebSite","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#website","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/","name":"\u682a\u5f0f\u4f1a\u793e\u65e5\u672c\u89e6\u5a92","description":"Nippon Shokubai\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"NIPPON SHOKUBAI | Nippon Shokubai\u2019s Health &amp; Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","og:type":"article","og:title":"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c | NIPPON SHOKUBAI","og:description":"Nippon Shokubai is going to exhibit at \u201cTIDES EUROPE 2024\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory","og:url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/","article:published_time":"2024-11-01T06:00:00+00:00","article:modified_time":"2024-11-01T05:36:01+00:00","twitter:card":"summary_large_image","twitter:title":"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c | NIPPON SHOKUBAI","twitter:description":"Nippon Shokubai is going to exhibit at \u201cTIDES EUROPE 2024\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory"},"aioseo_meta_data":{"post_id":"1424","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2024-11-01 00:03:42","updated":"2025-06-28 07:52:23","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/\" title=\"\u5bb6\">\u5bb6<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/\" title=\"Event\">Event<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tNippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u5bb6","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/"},{"label":"News","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/"},{"label":"Event","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/"},{"label":"Nippon Shokubai to Exhibit at \u201cTIDES EUROPE 2024\u201c","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1424\/"}],"_links":{"self":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/1424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":0,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/1424\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/media?parent=1424"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news_category?post=1424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}